teduglutide
| SMILES | CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1cnc[nH]1)N |
| InChIKey | CILIXQOJUNDIDU-ASQIGDHWSA-N |
| Sequence | HGDGSFSDEMNTILDNLAARDFINWLIQTKITD |
Chemical properties
| Hydrogen bond acceptors | 53 |
| Hydrogen bond donors | 55 |
| Rotatable bonds | 125 |
| Molecular weight (Da) | 3749.8 |
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| GLP-2 | GLP2R | Rat | Glucagon | B1 | pEC50 | 10.1 | 10.1 | 10.1 | ChEMBL |
| GLP-2 | GLP2R | Human | Glucagon | B1 | pEC50 | 8.0 | 8.0 | 8.0 | Drug Central |
| GLP-2 | GLP2R | Rat | Glucagon | B1 | pEC50 | 8.0 | 8.0 | 8.0 | Drug Central |
| GLP-2 | GLP2R | Human | Glucagon | B1 | pEC50 | 10.05 | 10.52 | 11.0 | ChEMBL |
| GLP-2 | GLP2R | Human | Glucagon | B1 | pEC50 | 10.7 | 10.7 | 10.7 | Guide to Pharmacology |